Posted Nov. 22, 2010 at 3:09 p.m.

Premium Lock IPO in the works: Tranzyme Pharma files for $75M stock offering

Published: 2010-11-22 15:09:13
Updated: 2010-11-22 15:09:13

Print this blog post
Tranzyme Tranzyme

The Triangle firm focuses on technology targeting gastrointestinal disorders and has announced two major partnerships over the past 11 months....Copyright 2013 WRAL Tech Wire. All rights reserved.

Please log in to view WRALTechWire Insider content


To access this premium content and other benefits, become a WRAL TechWire Insider. Daily, monthly, and annual memberships available.

Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Jim Roberts
Entrepreneurship
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Scroll